aluminum sulfate has been researched along with Chagas Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacon, KM; Bottazzi, ME; Cravioto, MB; de Leon Rosales, SP; Dumonteil, E; Fleischer, B; Heffernan, MJ; Hotez, PJ; Jones, K; Kamhawi, S; Lee, BY; Ortega, J; Slingsby, BT; Tapia-Conyer, R; Valenzuela, JG; Zhan, B | 1 |
| Manning, JE; Wrightsman, RA | 1 |
1 review(s) available for aluminum sulfate and Chagas Disease
| Article | Year |
|---|---|
Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Chagas Disease; Humans; Protozoan Vaccines; Vaccination; Vaccines, Subunit; Vaccines, Synthetic | 2012 |
1 other study(ies) available for aluminum sulfate and Chagas Disease
| Article | Year |
|---|---|
Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi.
Topics: Adenoviridae; Alum Compounds; Animals; CD4-Positive T-Lymphocytes; Chagas Disease; Immunity; Interleukin-12; Macrophages; Mice; Mice, Inbred C57BL; Protozoan Proteins; Protozoan Vaccines; Recombinant Proteins; Trypanosoma cruzi | 2000 |